Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

CompletedOBSERVATIONAL

Enrollment

197

Participants

Timeline

Start Date

July 16, 2021

Primary Completion Date

December 9, 2021

Study Completion Date

December 9, 2021

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Palbociclib + aromatase inhibitor

DRUG

Aromatase inhibitor

Trial Locations (1)

Pfizer New York, New York